Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital,...
Cath Lab
News | Antiplatelet and Anticoagulation Therapies | March 23, 2017
March 23, 2017 — In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low...
An MRI brain scan showing multiple microbleeds in a transcatheter aortic valve replacement (TAVR) patient from the study.
Feature | Heart Valve Technology | March 23, 2017
March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic...
The CardioGard embolic protection system for surgical aortic valve replacement.
Feature | Embolic Protection Devices | March 22, 2017
March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...
Feature | Heart Valve Technology | March 22, 2017
March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve...
Videos | Hemodynamic Support Devices | March 21, 2017
This video, provided by Abiomed, demonstrates the Impella percutaneous ventricular assist devices (pVAD). It offers...
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College...
Technology | Guidewires | March 20, 2017
March 20, 2017 — Teleflex Inc. recently announced 510(k) clearance by the U.S. Food and Drug Administration (FDA)...
Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions.
Feature | FFR Catheters | March 20, 2017
March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR...
Feature | Pharmaceuticals | March 20, 2017
March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology...
SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017.
News | Heart Valve Technology | March 17, 2017 | Dave Fornell
March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...
News | Stents Peripheral | March 16, 2017
March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...
News | Cardiac Imaging | March 16, 2017
March 16, 2017 — During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC),...
Technology | Angiography | March 15, 2017
March 15, 2017 — The U.S. Food and Drug Administration (FDA) has cleared the Artis pheno robotic C-arm...
Videos | Analytics Software | March 15, 2017
Pam Rush, RN, MS, clinical program director, cardiovascular service line, and Craig Strauss, M.D., MPH, medical...
